Tumor biology: Use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatments

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3361-3370

  Wexler, Eric J ^a   Gravallese, Ellen M ^b   Czerniak, Philip M ^a   Devenny, James J ^a   Longtine, Janina ^c   Wong, Michael K K ^d   Slee, Andrew M ^a   Kerr, Janet S ^a  

^a DUPONT COMPANY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLINE; CYCLOPHOSPHAMIDE; GEMCITABINE; MITOMYCIN C;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MICE; MICE, NUDE; MITOMYCIN; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033889190     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Plowman, J., Dykes, D. J., Hollingshead, M., Simpson-Herren, L., and Alley, M. C. Human tumor xenograft models in NCI drug development. In: B. A. Teicher (ed.), Anticancer Drug Development Guide. Preclinical Screening, Clinical Trials, and Approval, pp.101-125. Totowa, NJ: Humana Press Inc., 1997.
2. Dykes, D. J., Abbott, B. J., Mayo, J. G., Harrison, S. D., Jr., Laster, W. R., Jr., Simpson-Herren, L., and Griswold, D. P., Jr. Development of human tumor xenograft models for in vivo evaluation of new antitumor drugs. In: H. Huber and W. Queiber (eds.), Contributions to Oncology, Vol. 42, pp. 1-12. Basel: Karger, 1992.
3. Wright, J. E. Phosphoramide and oxazaphosphorine mustards. In: B. A. Teicher (ed.), Cancer Therapeutics. Experimental and Clinical Agents, pp. 23-80. Totowa, NJ: Humana Press Inc., 1997.
4. Giri, S. D., and Chatterjee, A. Modulation of mitomycin C-induced sister chromatid exchanges and cell cycle delay by buthionine sulfoximine and reduced glutatione in mouse bone marrow cells in vivo. Mutat. Res., 413: 227-234, 1998.
5. Boven, E., Schipper, H., Erkelens, C. A. M., Hatty, S. A., and Pinedo, H. M. The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer. Br. J. Cancer, 68: 52-56, 1993.
6. Fisher, R. I., Longo, D. L., DeVita, V. T., Jr., Hubbard, S. M., Miller, T. P., and Young, R. C. Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas. Ann. Oncol., 2 (Suppl. 1): 33-35, 1991.
7. Merriman, R. L., Hertel, L. W., Schultz, R. M., Houghton, P. J., Houghton, J. A., Rutherford, P. G., Tanzer, L. R., Boder, G. B., and Grindley, G. B. Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models. Invest. New Drugs, 14: 243-247, 1996.
8. Carmichael, J. The role of gemcitabine in the treatment of other tumours. Br. J. Cancer, 78 (Suppl. 3): 21-25, 1998.
9. Fan, W., Johnson, K. R., and Miller, M. C., III. In vitro evaluation of combination chemotherapy against human tumor cells (Review). Oncol. Rep., 5: 1035-1042, 1998.
10. Negoescu, A., Lorimier, P., Labat-Moleur, F., Drouet, C., Robert, C., Guillermet, C., Brambilla, C., and Brambilla, E. In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J. Histochem. Cytochem., 44: 959-968, 1996.
11. Barnhill, R. L., Peipkorn, M. W., Cochran, A. J., Flynn, E., Karaoli, T., and Folkman, J. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch. Dermatol., 134: 991-994, 1998.
12. McCarthy, N. J., and Evan, G. I. Methods for detection and quantifying apoptosis. Curr. Top. Dev. Biol., 36: 259-278, 1998.
13. Dolbeare, F. Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part I: historical perspectives, histochemical methods and cell kinetics. Histochem. J., 27: 339-369, 1995.
14. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.